The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...

As quality indicators and benchmarks for colonoscopy increase in coming years, gastroenterologists must think about ways to ...

Treatment is recommended in these cases. While surgery to treat nasal polyps is an option, there are several treatments to ...

REGN gets FDA nod for Dupixent for a broader population for the indication of chronic rhinosinusitis with nasal polyps.

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

In a recent study investigators established that extended dupilumab therapy-up to three years-is highly effective in the ...

The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab) to include add-on maintenance treatment of adolescent patients aged 12 to 17 years with inadequately ...

Blood in your bowels could be a sign of several potentially serious health conditions, and understanding the cause is crucial ...

Regeneron Pharmaceuticals and Sanofi have received Food and Drug Administration approval for their treatment of an inflammatory condition that affects the sinuses and nasal passages in adolescents, ...

GSK receives Japanese MHLW approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Thursday, August 29, 2024, 09:00 Hrs [IST] GSK plc announc ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.